A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

被引:63
作者
Cook, LS
White, E
Schwartz, SM
McKnight, B
Daling, JR
Weiss, NS
机构
[1] UNIV WASHINGTON, DEPT EPIDEMIOL, SEATTLE, WA 98195 USA
[2] UNIV WASHINGTON, DEPT BIOSTAT, SEATTLE, WA 98195 USA
关键词
breast neoplasms; menopausal status; second primary neoplasms; United States; women;
D O I
10.1007/BF00052945
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To evaluate predictors of contralateral breast cancer risk,we examined data from a nested case-control study of second primary cancers among a cohort of women in western Washington (United States) diagnosed with breast cancer during 1978 through 1990 and identified through a population-based cancer registry. Cases included all women in the cohort who subsequently developed contralateral breast cancer at least six months after the initial diagnosis, but prior to 1992 (n = 234). Controls were sampled randomly from the cohort, matched to cases on age, stage, and year of initial breast cancer diagnosis. Information on potential risk factors for second primary cancer was obtained through medical record abstractions and physician questionnaires, Women who were postmenopausal due to a bilateral oophorectomy (i.e., a surgical menopause) at initial breast cancer diagnosis had a reduction in contralateral breast cancer risk compared with premenopausal women (matched odds ratio [mOR] = 0.25, 95 percent confidence interval [CI] = 0.09-0.68), whereas no reduction in risk was noted among postmenopausal women who had had a natural menopause (mOR = 0.90, CI = 0.39-2.09). Among postmenopausal women, there was a suggestion of a lower risk associated with relatively high parity (2+). A family history of breast cancer was associated with an increased risk (mOR = 1.96, CI = 1.22-5.15) and varied little by menopausal status, Having an initial tumor with a lobular component (c.f. a ductal histology) was not related strongly to risk (mOR = 1.47, CI = 0.79-2.74), The results of the present and earlier studies argue that we have limited ability to predict the occurrence of a contralateral breast tumor. Better predictors will be required before diagnostic and preventive interventions can be targeted to subgroups of patients with unilateral breast cancer.
引用
收藏
页码:382 / 390
页数:9
相关论文
共 38 条
[1]  
ABE O, 1992, LANCET, V339, P71
[2]  
[Anonymous], 1992, Lancet, V339, P1
[3]  
[Anonymous], IARC SCI PUB
[4]  
[Anonymous], 1982, EPIDEMIOLOGIC RES
[5]  
ARMSTRONG BK, 1992, MONOGR EPI BIOSTAT
[6]   ADJUVANT CHEMOTHERAPY IN EARLY BREAST-CANCER AND INCIDENCE OF NEW PRIMARY MALIGNANCIES [J].
ARRIAGADA, R ;
RUTQVIST, LE .
LANCET, 1991, 338 (8766) :535-538
[7]   THE GENETIC EPIDEMIOLOGY OF 2ND PRIMARY BREAST-CANCER [J].
BERNSTEIN, JL ;
THOMPSON, WD ;
RISCH, N ;
HOLFORD, TR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (08) :937-948
[8]   RISK-FACTORS PREDICTING THE INCIDENCE OF 2ND PRIMARY BREAST-CANCER AMONG WOMEN DIAGNOSED WITH A 1ST PRIMARY BREAST-CANCER [J].
BERNSTEIN, JL ;
THOMPSON, WD ;
RISCH, N ;
HOLFORD, TR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (08) :925-936
[9]   CANCER IN THE CONTRALATERAL BREAST AFTER RADIOTHERAPY FOR BREAST-CANCER [J].
BOICE, JD ;
HARVEY, EB ;
BLETTNER, M ;
STOVALL, M ;
FLANNERY, JT .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (12) :781-785
[10]  
BURNS PE, 1984, CAN MED ASSOC J, V130, P881